While some of the current biomarkers require a tumor tissue biopsy for assessment limited by tumor heterogenicity and difficulties in obtaining fresh tumor material, the collagen remodeling biomarkers C4G and PRO-C3 are measured non-invasively in a liquid biopsy, with the advantages of being homogeneous and easy to obtain. The gene discussed is C3; the disease is neoplasm.